Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Revelation Biosciences Inc (REVB)

Revelation Biosciences Inc (REVB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Revelation Biosciences Inc 4660 LAJOLLA VILLAGE DRIVE SUITE 100 SAN DIEGO CA 92122 USA

www.revbiosciences.com Employees: 9 P: 650-800-3717

Sector:

Medical

INDUSTRY GROUPING:

Medical - Biomedical

Description:

Revelation Biosciences Inc. is a clinical-stage life sciences company. It focused on the development of immunologic-based therapies for the prevention and treatment of disease. The company's product pipeline includes REVTx-99, REVTx-200 and REVDx-501. Revelation Biosciences Inc., formerly known as Petra Acquisition Inc., is based in NEW YORK.

Key Statistics

Overview:

Market Capitalization, $K 4,931
Enterprise Value, $K -1,569
Shares Outstanding, K 5,924
Annual Sales, $ 0 K
Annual Net Income, $ -15,040 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -1,910 K
EBIT, $ -8,240 K
EBITDA, $ -8,210 K
60-Month Beta -0.11
% of Insider Shareholders 14.24%
% of Institutional Shareholders 12.80%
Float, K 5,080
% Float 85.76%
Short Interest 29
Short Float 0.49%
Short Volume Ratio 0.37

Growth:

1-Year Return -95.76%
3-Year Return -99.99%
5-Year Return -100.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -1.77 on 11/06/25
Next Earnings Date 03/05/26
Earnings Per Share ttm -30.05
EPS Growth vs. Prev Qtr 74.75%
EPS Growth vs. Prev Year 95.61%
Annual Dividend & Yield 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 1-3 on 07/07/25

REVB Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -145.03%
Return-on-Assets % -112.72%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 0.29
Book Value/Share 3.06
Interest Coverage -2.40
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar